Stock Code: 002082
Stock Abbreviation: ST Wanbang
Announcement No.: 2026-052
Wanbangde Pharmaceutical Holdings Group Co., Ltd.
Announcement on Progress and Risk Warning Regarding the Company's Stock Trading Being Subject to Other Risk Warnings
The Company and all members of the Board of Directors guarantee the content of this information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
I. Situation Regarding the Company's Stock Trading Being Subject to Other Risk Warnings
Beijing Dehao Certified Public Accountants (Special General Partnership) (hereinafter referred to as "Beijing Dehao"), the company's 2025 annual audit firm, issued a disclaimer of opinion on the company's internal controls for the year 2025.
According to Article 9.8.1, Item (IV) of the Shenzhen Stock Exchange Stock Listing Rules (hereinafter referred to as the "Listing Rules"), due to the audit report on internal controls over financial reporting for the most recent fiscal year receiving a disclaimer of opinion, the company's stock trading has been subject to other risk warnings by the Shenzhen Stock Exchange.
II. Measures Taken and Progress of Related Work
The Company's Board of Directors attaches great importance to the matters involved in the non-standard audit opinion. The Company's management is actively taking measures to strive to eliminate the impact of the company's stock trading being subject to other risk warnings as soon as possible. The specific situation is as follows: